@Davisite
Apologies if I appeared haste to jump down your throat, however I feel you're just cherry picking info.
Yes, it appears they're intending to spend 1.98m this Qtr.
However what you failed to mention (intentionally or unintentionally - I'm not casting an aspersion either way) is that $1.35m of that spend this Qtr is on R&D.
AND... they will get 43% of the R&D spend back by way of a cash rebate via the ATO.
So - net net - they're going to spend 1.3m this Qtr
They started the Qtr with 7m, less 1.3m spend equals $5.7m. Then we add the $300k they received this Qtr from a R&D rebate - they should finish the Qtr with $6m cash
All I'm saying is that they launched the IPO last year with the intention to be fully funded to take the product to market & they are on track to achieve that goal.
2019 is the year of delivery.
An opinion on the commercial prospects of RHY, page-7
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RHY (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.41M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5969 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 5500 | 1 |
View Market Depth
| Last trade - 16.16pm 18/11/2024 (20 minute delay) ? |
| RHY (ASX) Chart |
Day chart unavailable
